Invention relates to pharmaceutical formulation for enhancing the oral bioavailability of a prodrug ester as a non-aqueous formulation by formulating the ester prodrug such as Cefuroxime axetil with medium chain triglycerides. The prodrug is selected from antibiotics, corticosteroids, Non-Steroidal anti-inflammatory drugs, Anti-retroviral and Angiotensin II antagonists. The Preparation method is simple, cost effective, practical and reproducible for enhancement of the bioavailability.
Technologies